Form 8-K - Current report:
SEC Accession No. 0001493152-21-031725
Filing Date
2021-12-16
Accepted
2021-12-16 16:42:00
Documents
14
Period of Report
2021-12-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35240
2 ex99-1.htm EX-99.1 13934
3 ex99-1_001.jpg GRAPHIC 6877
  Complete submission text file 0001493152-21-031725.txt   235779

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abeo-20211216.xsd EX-101.SCH 3055
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abeo-20211216_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abeo-20211216_pre.xml EX-101.PRE 22379
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3609
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 211498235
SIC: 2834 Pharmaceutical Preparations